A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.
HP6019-07
Phase 1 other active
Quick answer
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants. for Not applicable for phase I study is a Phase 1 program (other) at Gruenenthal GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gruenenthal GmbH
- Indication
- Not applicable for phase I study
- Phase
- Phase 1
- Modality
- other
- Status
- active